March, 2019, Ambrx, Inc. and BeiGene, Ltd announced a global research and development collaboration. BeiGene is a global, commercial-stage, research-based biotechnology company focused on immuno-oncology cancer therapeutics. With a team of over 2,200 employees in...
JP Morgan Week is fast approaching, that annual time when one of the world’s leading investment and banking firms looks to the future. Business professionals from almost every industry and sector attend conferences during this time to learn more about what’s to come...
China pharma sector, the second largest in the world, continues to grow rapidly on a CAGR of 10%, which will reach ~$393 Billion in 2025. Key regulatory changes • China Joined ICH in 2017: fast drug approval and match the global standards • NRDL (National...
Featuring 1-on-1 meeting opportunities, China [email protected] Francisco will take place on Jan 12, 2020, in San Francisco. Almost 200 business leaders and enthusiastic investors are ready to schedule personal meetings with you! With our instant online scheduling platform,...
Introduction J.P. Morgan 38th Annual Healthcare Conference (JPM 2020) will take place 13-16 January 2020 in San Francisco, CA, USA. The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry,...
In 2018, Chinese companies made more than 150 cross-border life sciences licensing deals, with the average upfront payment of ~$10 Million, having reached a record high. Over 40% of early- and late-stage assets entered China market through licensing deals. In this...
Recent Comments